- Home
- TSVT vs AGD Comparison
TSVT vs AGD Comparison
Compare TSVT & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- AGD
- Stock Information
- Founded
- TSVT 2021
- AGD 2006
- Country
- TSVT United States
- AGD United Kingdom
- Employees
- TSVT N/A
- AGD N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- AGD Trusts Except Educational Religious and Charitable
- Sector
- TSVT Health Care
- AGD Finance
- Exchange
- TSVT Nasdaq
- AGD Nasdaq
- Market Cap
- TSVT 258.9M
- AGD 253.4M
- IPO Year
- TSVT N/A
- AGD N/A
- Fundamental
- Price
- TSVT $4.95
- AGD $9.97
- Analyst Decision
- TSVT Buy
- AGD
- Analyst Count
- TSVT 5
- AGD 0
- Target Price
- TSVT $7.60
- AGD N/A
- AVG Volume (30 Days)
- TSVT 2.5M
- AGD 61.2K
- Earning Date
- TSVT 03-25-2025
- AGD 01-01-0001
- Dividend Yield
- TSVT N/A
- AGD 8.13%
- EPS Growth
- TSVT N/A
- AGD N/A
- EPS
- TSVT N/A
- AGD N/A
- Revenue
- TSVT $37,862,000.00
- AGD N/A
- Revenue This Year
- TSVT $72.76
- AGD N/A
- Revenue Next Year
- TSVT $25.59
- AGD N/A
- P/E Ratio
- TSVT N/A
- AGD N/A
- Revenue Growth
- TSVT N/A
- AGD N/A
- 52 Week Low
- TSVT $2.29
- AGD $8.20
- 52 Week High
- TSVT $5.99
- AGD $9.78
- Technical
- Relative Strength Index (RSI)
- TSVT 80.79
- AGD 39.97
- Support Level
- TSVT $2.55
- AGD $10.03
- Resistance Level
- TSVT $4.97
- AGD $10.30
- Average True Range (ATR)
- TSVT 0.01
- AGD 0.10
- MACD
- TSVT -0.00
- AGD -0.02
- Stochastic Oscillator
- TSVT 60.00
- AGD 8.33
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.